These stocks have bucked the cascading fall. Are they worth buying? Debashis Basu and Shailendra Lotlikar analyse

The climate for stocks couldn’t be worse: high crude prices, political flux, stalled reforms in a pre-election year, poor governance (subsidies, write-offs and pay rises for government employees), rising inflation, escalating interest rates, a dramatically widening balance of...

A down move may start soon taking the Sensex to 12,200                                                                                                             

In the previous issue, I had mentioned that the current environment is best suited for playing the short swings. I had suggested that from now on, we would find the market moving down one day and up two days and vice versa. Or,...

A few weeks ago, Glenmark Pharmaceuticals Ltd announced that it bought seven pharmaceutical brands in Poland, the largest pharmaceutical market in Central and East Europe. Glenmark has estimated that sales of the acquired product portfolio for FY09 will be $15 million. Amid all the talk of a slowdown and market crash, this small piece of news went unnoticed. But it was yet another in a series...